Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis

Immune checkpoint inhibitor-associated colitis (ICIC) affects approximately 15% of cancer patients treated with immunotherapy. Although histological evaluation is potentially valuable for both the diagnosis of ICIC and evaluation of disease activity, use in clinical practice is heterogeneous. We aim...

Descripció completa

Dades bibliogràfiques
Autors principals: Brian G Feagan, Vipul Jairath, Reetesh K Pai, Rish K Pai, Amitabh Srivastava, Christopher Ma, Christophe Rosty, David F Schaeffer, Roger M Feakins, Gregory Y Lauwers, Jonathan Krell, Richard Kirsch, Leonardo Guizzetti, John K MacDonald, Won-Tak Choi, Stefanie C McFarlane, Joanna C. Walsh
Format: Article
Idioma:English
Publicat: BMJ Publishing Group 2022-03-01
Col·lecció:Journal for ImmunoTherapy of Cancer
Accés en línia:https://jitc.bmj.com/content/10/3/e004560.full

Internet

https://jitc.bmj.com/content/10/3/e004560.full

Ítems similars